Related Experiment Video

Updated: Jun 23, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Hypertension and cardiac failure in its various forms

Krishna K Gaddam1, Anil Verma, Mark Thompson

  • 1Department of Medicine, Division of Cardiovascular Diseases, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.

The Medical Clinics of North America
|May 12, 2009
PubMed

Insights

Hypertension significantly raises heart failure risk. Early recognition and treatment of hypertension and hypertensive heart disease are crucial for prevention and improved survival, especially with effective antihypertensive drugs.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Heart Failure Studies

Background:

  • Hypertension is a primary risk factor for both systolic and diastolic heart failure.
  • Increasing life expectancy and cardiovascular disease treatments contribute to a rising prevalence of heart failure.
  • Heart failure is a major cause of cardiovascular morbidity and mortality.

Purpose of the Study:

  • To emphasize the importance of early hypertension recognition and treatment in preventing heart failure.
  • To review the efficacy of various antihypertensive drug classes in managing hypertensive heart disease.
  • To highlight challenges in treating heart failure with preserved ejection fraction.

Main Methods:

  • Review of existing literature on hypertension and heart failure.
  • Analysis of antihypertensive drug classes' effects on left ventricular hypertrophy (LVH) and heart failure.
  • Discussion of current treatment strategies for heart failure with preserved ejection fraction.

Main Results:

  • Antihypertensive medications, excluding direct vasodilators, can reverse LVH and prevent heart failure.
  • Most major antihypertensive drug classes, notably beta-blockers and RAS antagonists, improve survival in LV systolic dysfunction.
  • Treating heart failure with preserved ejection fraction remains largely empiric, focusing on blood pressure and volume management.

Conclusions:

  • Effective management of hypertension is key to reducing heart failure incidence and improving patient outcomes.
  • While treatments exist for LVH and systolic dysfunction, diastolic dysfunction and HFpEF require further research and targeted therapies.
  • Controlling blood pressure and fluid balance are current cornerstones for managing heart failure with preserved ejection fraction.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...